Remicade Rheumatoid Arthritis X-Ray Data Sealed J&J Purchase Of Centocor
Executive Summary
Interim data from Centocor's Remicade in rheumatoid arthritis, initially available to the company in mid-June, convinced Johnson & Johnson to purchase the biotechnology company.